LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.40 | 84.90 | 1315 | 1454 | 0.9040 | 0.9514 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.40 | 84.90 | 36 | 1454 | 0.0247 | -0.1889 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.40 | 84.90 | 1863 | 1454 | 1.2807 | 1.1244 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.10 | 84.90 | 29 | 1616 | 0.0179 | -0.2233 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.10 | 84.90 | 1377 | 1616 | 0.8520 | 0.9260 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.10 | 84.90 | 53 | 1616 | 0.0328 | -0.1049 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 23.10 | 84.90 | 2001 | 1616 | 1.2381 | 1.1030 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.81 | 84.90 | 48 | 1769 | 0.0271 | -0.1220 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.81 | 84.90 | 1471 | 1769 | 0.8313 | 0.9174 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.81 | 84.90 | 61 | 1769 | 0.0345 | -0.0727 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.81 | 84.90 | 2123 | 1769 | 1.1998 | 1.0849 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 26.51 | 84.90 | 75 | 1923 | 0.0390 | -0.0272 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 26.51 | 84.90 | 1592 | 1923 | 0.8278 | 0.9178 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 26.51 | 84.90 | 75 | 1923 | 0.0390 | -0.0272 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 26.51 | 84.90 | 2228 | 1923 | 1.1585 | 1.0664 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 28.21 | 84.90 | 87 | 2091 | 0.0416 | 0.0053 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 28.21 | 84.90 | 1717 | 2091 | 0.8209 | 0.9164 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 28.21 | 84.90 | 79 | 2091 | 0.0378 | -0.0155 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 28.21 | 84.90 | 2397 | 2091 | 1.1461 | 1.0599 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.92 | 84.90 | 91 | 2237 | 0.0407 | 0.0148 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.92 | 84.90 | 1851 | 2237 | 0.8272 | 0.9212 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.92 | 84.90 | 83 | 2237 | 0.0371 | -0.0048 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.92 | 84.90 | 2602 | 2237 | 1.1628 | 1.0649 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 31.62 | 84.90 | 70 | 2449 | 0.0286 | -0.0390 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 31.62 | 84.90 | 2067 | 2449 | 0.8438 | 0.9312 | MN20160318_Q02 | E19 |